Justin Li

Mr. Justin Li

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
SNSiew Fei Ngu
Siew Fei Ngu
YCYu Ka Chai
Yu Ka Chai
KCKa Man Choi
Ka Man Choi
TLTsin Wah Leung
Tsin Wah Leung
JLJustin Li
Justin Li
KCKaren KL Chan
Karen KL Chan
The accurate prediction of malignancy for a pelvic mass detected on ultrasound allows for appropriate referral to specialised care. IOTA simple rules are one of the best methods but are inconclusive in 25% of cases, where subjective assessment by an expert sonographer is recommended but may not always be available. In the present paper, we evaluate the methods for assessing the nature of a pelvic mass, including IOTA with subjective assessment by expert ultrasound, RMI and ROMA. In particular, we investigate whether ROMA can replace expert ultrasound when IOTA is inconclusive. This prospective study involves one cancer centre and three general units. Women scheduled for an operation for a pelvic mass underwent a pelvic ultrasound pre-operatively. The final histology was obtained from the operative sample. The sensitivity, specificity and accuracy for each method were compared with the McNemar test. Of the 690 women included in the study, 171 (25%) had an inconclusive IOTA. In this group, expert ultrasound was more sensitive in diagnosing a malignant mass compared to ROMA (81% vs. 63%, p = 0.009) with no significant difference in the specificity or accuracy. All assessment methods involving IOTA had similar accuracies and were more accurate than RMI or ROMA alone. In conclusion, when IOTA was inconclusive, assessment by expert ultrasound was more sensitive than ROMA, with similar specificity.

SNSiew Fei Ngu
Siew Fei Ngu
LLLesley Lau
Lesley Lau
JLJustin Li
Justin Li
GWGrace C. Y. Wong
Grace C. Y. Wong
ACAnnie NY Cheung
Annie NY Cheung
KCKaren KL Chan
Karen KL Chan
The aim of this study was to assess the effectiveness of HPV self-sampling for cervical cancer screening and the best means of service delivery, with a specific focus on under-screened women, particularly during the COVID-19 pandemic. Using three arms of service delivery (social media, school outreach and underserved outreach), we recruited under-screened women aged 30–65 years from two population groups: the general public and specific underserved communities, from whom self-sampled specimens and optional clinician-sampled cervical specimens were obtained for HPV testing. A total of 521 self-sampling kits were distributed, of which 321 were returned, giving an overall uptake rate of 61.6%. The response rate was higher in the face-to-face underserved outreach (65.5%) compared to social media (22.8%) and school outreach (18.2%). The concordance for HPV detection between self-sampled and clinician-sampled specimens was 90.2% [95% confidence interval (CI) 85.1–93.8%; Cohen’s kappa 0.59 (95% CI 0.42–0.75)]. Overall, 89.2% of women were willing to have self-sampling again. In conclusion, HPV self-sampling is an effective method for cervical cancer screening and can be considered as an option, particularly in women who are reluctant or unable to attend regular screening. Various service deliveries could be considered to increase participation in cervical cancer screening.

1 June 2017 in Minerva Cardiology and Angiology
Verified
Journal Article
Closed access
SSSubothini Selvendran
Subothini Selvendran
NANikhil Aggarwal
Nikhil Aggarwal
JLJustin Li
Justin Li
GTGary Tse
Gary Tse
VVVassilios S. Vassiliou
Vassilios S. Vassiliou
Article: The role of myocardial fibrosis in determining the success rate of ablation for the treatment of atrial fibrillation - Minerva Cardioangiologica 2017 August;65(4):420-6 - Minerva Medica - Journals

12 May 2025 in Hong Kong Journal of Gynaecology, Obstetrics and Midwifery
Verified
Journal Article
Open access
PDF file
JLJustin Li
Justin Li
MCMei Chi Cheng
Mei Chi Cheng
Uterine fibroids are found in up to 70% of women by the age of 50 years, of whom up to 40% experience symptoms including heavy menstrual bleeding, urinary or bowel dysfunction, pelvic discomfort, pressure symptoms, reproductive dysfunction, and mood disturbances. Uterine fibroids have a detrimental effect on quality of life and cause a large proportion of gynaecological hospitalisations. Although hysterectomy is the definitive treatment, up to 3% and 4% of patients experience intra- and post-operative complications, respectively. Moreover, hysterectomy is unacceptable in women who wish to preserve their fertility. Medical management of uterine fibroids includes hormonal and nonhormonal (tranexamic acid) medications. Commonly used hormonal medications include combined oral contraceptives and progestogens, levonorgestrel-releasing intrauterine devices, selective progesterone receptor modulators, and gonadotrophin receptor agonists and antagonists. Other less commonly used agents include androgens, selective oestrogen receptor modulators, androgens, and aromatase inhibitors. Minimally invasive interventions includeuterine artery embolisation, high-intensity focused ultrasound, and radiofrequency ablation. Treatment should be personalised to suit each woman’s needs without compromising fertility, reproductive, or obstetric outcomes. Surgery must still be considered when symptoms are intractable, malignancy is suspected, or in an emergency setting in which fibroid-related complications such as torsion or obstructive uropathy arise. Shared decision making is essential, particularly in women of reproductive age, to balance efficacy, fertility goals, and treatment risks.